Title : ADAM-17: a novel therapeutic target for triple negative breast cancer.

Pub. Date : 2013 Feb

PMID : 22967992






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The ADAM-17 specific inhibitor, PF-5480090 (TMI-002, Pfizer) was tested in a panel of breast cancer cell lines for effects on functional outputs. pyrazofurin ADAM metallopeptidase domain 17 Homo sapiens